HeartBeam Inc. Advances Cardiac Care with New Patents for 3D ECG Technology

HeartBeam Inc. (NASDAQ: BEAT) has recently been granted two new U.S. patents, further cementing its role as a pioneer in the field of digital cardiac care. These patents cover the company's compact, cable-free 3D ECG device and a sophisticated rhythm analysis algorithm, both designed to revolutionize how cardiac conditions are diagnosed and monitored outside traditional medical facilities.

The 3D ECG device stands out for its ability to collect high-fidelity cardiac signals from three non-coplanar directions using chest and finger electrodes. This innovation allows for on-demand symptom recording and the synthesis of 12-lead ECGs, offering a level of convenience and accuracy previously unattainable in remote settings. Currently under FDA review, the device's software is supported by data from the VALID-ECG pivotal study, underscoring its potential to transform cardiac diagnostics.

Equally noteworthy is the rhythm analysis algorithm, which enhances diagnostic precision by triggering targeted data collection during abnormal rhythm detection. This feature is compatible across various cardiac monitoring systems, making it a versatile tool in the fight against arrhythmias. With these advancements, HeartBeam is not only expanding its intellectual property portfolio but also setting the stage for the integration of AI capabilities to further improve diagnostic accuracy.

The implications of these developments are profound. For patients, the ability to receive accurate, real-time cardiac diagnostics outside of a hospital setting could significantly improve outcomes, especially for those in remote or underserved areas. For the healthcare industry, HeartBeam's technology represents a leap forward in telemedicine and remote patient monitoring, potentially reducing the need for in-person visits and lowering healthcare costs. With 20 issued patents and 34 additional filings, HeartBeam is at the forefront of a shift towards more accessible, efficient, and effective cardiac care.